Theragenics Corporation Sustainability Profile
Theragenics Corporation, a prominent player in the medical device industry, is headquartered in the United States. Founded in 1996, the company has established itself as a leader in the development of innovative solutions for cancer treatment, particularly in the field of brachytherapy. With a focus on prostate cancer, Theragenics offers a range of unique products, including its proprietary seed implants, which are designed to deliver targeted radiation therapy. Over the years, Theragenics has achieved significant milestones, enhancing its market position through strategic partnerships and advancements in technology. The company is recognised for its commitment to quality and patient care, making it a trusted name among healthcare professionals. With operations extending across key regions in the US, Theragenics continues to drive innovation in cancer treatment, solidifying its reputation as a vital contributor to the medical community.
DitchCarbon Score
How does Theragenics Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Theragenics Corporation's score of 18 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Theragenics Corporation's reported carbon emissions
Theragenics Corporation, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Theragenics may not have established formal commitments to address carbon emissions or climate change initiatives at this time. As such, the company does not inherit any emissions data from a parent or related organization, nor does it participate in recognised climate initiatives like the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP).
How Carbon Intensive is Theragenics Corporation's Industry?
How Carbon Intensive is Theragenics Corporation's Location?
Theragenics Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Theragenics Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
